|

Chemotherapy Induced Neuropathy in Cancer Patients

RECRUITINGSponsored by Swami Rama Himalayan University
Actively Recruiting
SponsorSwami Rama Himalayan University
Started2022-11-23
Est. completion2024-08-20
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06491082

Summary

The purpose of this prospective study is to perform Nerve conduction test, Vitamin D, Vitamin B12 and NADPH oxidase 4(NOX4) expression to assess severity of chemotherapy induced Peripheral neuropathy (CIPN) in solid cancer (Head and Neck, Breast, Prostate) patients who planned for at least 4 cycle of chemotherapy in different nutrient status level and gene expression.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All patients receiving chemotherapy for solid cancer
* Patient aged\>18years

Exclusion Criteria:

* Age ≤ 18 years
* Pre-existing neuropathy
* Patients diagnosed with Psychiatric illness
* Patients with pre-existing peripheral neuropathy
* Patients taking medication for neuropathy
* Long standing diabetes (\>10 years)
* Renal and Hepatic disease

Conditions2

CancerChemotherapy-induced Peripheral Neuropathy

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.